Magnesium intake and the incidence of type 2 diabetes

New Perspectives in Magnesium Research: Nutrition and Health

Volumn , Issue , 2007, Pages 143-154

  Guerrero Romero, Fernando ^a,b   Rodríguez Morán, Martha ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54049110833     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-483-0_12     Document Type: Chapter

References (64)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
2. DeFronzo RA. Lilly Lecture 1987. The triumvirate: B-cell, muscle, liver. A collision responsible for NIDDM. Diabetes 1998;37:667-687
3. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic infl ammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 2003;52:1799-1805
4. Schulze MB, Hoffmann K, Manson JA, et al. Dietary pattern, infl ammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005;82:675-684
5. Pickup JC. Infl ammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823
6. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-1200
7. Sullivan PW, Morrato EH, Ghushchyan V, et al. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005;28:1599-1503
8. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-213
9. Mykkanen L, Laakso M, Uusitupa M, et al. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990;13:1099-1105
10. Lapidus L, Bengtsson C, Lissner L, et al. Family history of diabetes in relation to different types of obesity and change of obesity during 12-yr period. Results from prospective population study of women in Goteborg, Sweden. Diabetes Care 1992;15:1455-1458
11. Wilson FH, Hariri A, Farhi A, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004;306:1190-1194
12. Weyer Ch, Bogardus C, Mott DM, et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794
13. Durlach J, Bac P, Durlach V, et al. Magnesium status and ageing: An update. Magnes Res 1998;11:25-42
14. Guerrero-Romero F, Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002;26:469-474
15. Malpuech-Brugere C, Nowacki W, Daveau M, et al. Infl ammatory response following acut magnesium deficiency in the rat. Biochim Biophys Acta 2000;15; 1501:91-98
16. Song Y, Manson JE, Buring JE, et al. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004;27:59-65
17. Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134-140
18. Colditz GA, Manson JE, Stampfer MJ, et al. Diet and risk of clinical diabetes in women. Am J Clin Nutr 1992;55:1018-1023
19. Meyer KA, Kushi LH, Jacobs DR Jr, et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000;71:921-930
20. Alzaid AA, Dinneen SF, Moyer TP, et al. Efects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance. J Clin Endocrinol Metab 1995;80:1376-1381
21. White JR Jr, Campbell RK. Magnesium and diabetes: A review. Ann Pharmacother 1993;27:775-780
22. Ma J, Folson AR, Melnick SL, et al. Association of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. J Clin Epidemiol 1995;48:927-940
23. Guerrero-Romero F, Tamez-Perez HE, González-González G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253-258
24. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in Type 2 diabetic subjects. A randomized, double-blind controlled trial. Diabetes Care 2003;26:1147-1152
25. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 2004;61:1569-1576
26. Fox C, Ramsoomair D, Carter C. Magnesium: Its proven and potential clinical signifi cance. South Med J 2001;94:1195-1201
27. Guerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res 2005;36:250-257
28. Lukaski HC. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr 2000;72:585S-593S
29. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am J Hypertens 1997;10:346-355
30. Ebel H, Gunther T. Magnesium metabolism: A review. J Clin Chem Biochem 1980;18:257-270
31. Suarez A, Pulido N, Casla A, et al. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995;38:1262-1270
32. Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003;24:39-52
33. Rodríguez-Morán M, Guerrero-Romero F. Elevated serum concentration of tumor necrosis factor-Alpha is linked to low serum magnesium levels in the obesityrelated infl ammatory response. Magnes Res 2004;17:189-196
34. Saris NE, Mervaala E, Karppanen H, et al. Magnesium: An update on physiological, clinical and analytical aspects. Clin Chem Acta 2000;294:1-26
35. Jones JE, Manalao R, Flink EB. Magnesium requirements in adults. Am J Clin Nutr 1967;20:632-635
36. Pennington JA, Schoen SA. Total diet study: Estimated dietary intakes of nutritional elements 1982-1992. Int J Vitam Nutr Res 1996;66:350-362
37. Galan P, Preziosi P, Durlach V, et al. Dietary magnesium intake in a French adult population. Magnes Res 1997;10:321-328
38. Ford ES. Race, education, and dietary cations: Fi ndings from the Third National Health and Nutrition Examination Survey. Ethn Dis 1998;8:10-20
39. Ford ES. Dietary magnesium intake in a National Sample of U.S. adults. J Nutr 2003;133:2879-2882
40. Kawano Y, Matsuoka H, Takishita S, et al. Effects of magnesium supplementation in hypertensive patients: Assessment by offi ce, home, and ambulatory blood pressures. Hypertension 1998;32:260-265
41. Lefebvre PJ, Paolisso G, Scheen AJ. Magnesium and glucose metabolism. Therapie 1994;49:1-7
42. Kisters K, Spieker C, Tepel M, et al. New data about the effect of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993;6:355-360
43. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications 2000;14:272-276
44. Grifò G, Lo Presti R, Montana M, et al. Plasma, erythrocyte and platelet magnesium in essential hypertension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease. Recenti Prog Med 1995; 86:431-436
45. 2+ in etiology of diabetic complications. Diabetes 1992;41:35-39
46. Rodríguez-Morán M, Guerrero-Romero F. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Arch Med Res 2001;32:300-303
47. Kao WHL, Folsom AR, Nieto FJ, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-2159
48. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997;20:545-550
49. Salmeron J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997;277:472-477
50. Hodge AM, English DR, O'Dea K, et al. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004;27:2701-2706
51. Balon TW, Gu JL, Tokuyama Y, et al. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 1995;269: E745-E752
52. Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992;55:1161-1167
53. Yokota K, Kato M, Lister F, et al. Clinical Efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 2004;23:506S-509S
54. Paoliso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type 2) diabetic patients. J Clin Endocrinol Metab 1994;78:1510-1514
55. Eibl NL, Koop HP, Nowak HR, et al. Hypomagnesemia in type 2 diabetes: Effect of a 3-month replacement therapy. Diabetes Care 1995;18:188-192
56. de Valk HW, Verkaaik R, van Rijn HJM, et al. Oral magnesium supplementation in insulin-requiring type 2 patients. Diabet Med 1998;15:503-507
57. Lima M de L, Cruz T, Pousada JC, et al. The effect of Magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21: 682-686
58. Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 1994;17: 460-461
59. Paolisso G, Sgambato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989;12:265-269
60. Nadler JL, Buchanan T, Natarajan R, et al. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21:1024-1029
61. Fung TT, Manson JE, Solomon CG, et al. The association between magnesium intake and fasting insulin concentration in healthy middle-Aged women. J Am Coll Nutr 2003;22:533-538
62. Rosolova H, Mayer O, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 1997;82:3783-3785
63. Rosolova H, Mayer OJ, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000;49:418-420
64. Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic black Americans. Am J Hypertens 1999;12:747-756.